您当前所在位置: 首页 > 学者
在线提示

恭喜!关注成功

在线提示

确认取消关注该学者?

邀请同行关闭

只需输入对方姓名和电子邮箱,就可以邀请你的同行加入中国科技论文在线。

真实姓名:

电子邮件:

尊敬的

我诚挚的邀请你加入中国科技论文在线,点击

链接,进入网站进行注册。

添加个性化留言

已为您找到该学者13条结果 成果回收站

上传时间

2005年03月11日

上传时间

2005年03月11日

上传时间

2005年03月11日

【期刊论文】ESTABLISHMENT OF A METASTATIC MODEL OF HUMAN HEPATOCELLULAR CARCINOMA IN NUDE MICE VIA ORTHOTOPIC IMPLANTATION OF HISTOLOGICALLY INTACT TISSUES

汤钊猷, Fan X.SUN, Zhao Y.TANG, , Kang D.LIU, Sheng L.YE, Qiong XUE, Dong M.GAO and Zeng C.MA

,-0001,():

-1年11月30日

摘要

A highly metastatic LCI•D20 model of human hepatocellular carcinoma (HCC) was obtained via orthotopic implantation of a histologically preserved metastatic tumour selected from I of 30 surgical specimens, and has been maintained for 18 passages in nude mice. All mice with transplanted tumours exhibited 100% transplantability and metastatic ability, as well as various manifestations reminiscent of tumour behaviour in HCC pa-tients. These included: local growth, regional invasion, spontane-ous metastasis to liver, lymph nodes and lungs, and peritoneal seeding, Histological characteristics of the LCI-D20 tumour were similar to those of the original tumour. Karyotypic analysis revealed heteroploid cells. Immunohistochemically, expression of AFP and HBXAG was shown, Our nude mouse model with its high metastatic rate and short latency period could be an interesting tool for the study of human HCC.

上传时间

2005年03月11日

【期刊论文】Cytoreduction and Sequential Resection for Surgically Verified Unresectable Hepatocellular Carcinoma: Evaluation with Analysis of 72 Patients

汤钊猷, Zhao-You Tang, M.D., Ye-Qin Yu, Xin-Da Zhou, Zeng-Chen Ma, M. D., Ji-Zhen Lu, Zhi-Ying Lin, Kang-Da Liu, Sheng-Long Ye, Bing-Hui Yang, Hong-Wei Wang, Hui-Chuan Sun

,-0001,():

-1年11月30日

摘要

The poor prognosis of hepatocellular carcinoma (HCC) was partly a result of the majority of unresectable HCCs in clinical patients. Fortunately, with the progress of regional cencer therapics and multimo-dality trealent, some of the licalized unresectable HCCs were converted to resectable ones. During the period 1960-1994, 72 of the 663 patients with surgically verified unresectable HCCs have been converted to resectable ones. During the period 1960-1994, 72 of the 663 patients with surgically verified unreseetable HCCs have been converted to rescctable. Sucessful cytoreduction with median diameter reduced from 10 cm to 5 cm was mainly a result of the triple or double combination treatment with hepatic artery ligation, hepatic artery cannulation with infusion, radioimmunotherapy. and fractionated regional radiotherapy. The interval hetween the first operation and the sequential reection was 5 months. The operative mortality was 1.4% for sequential resection, and the 5-year sursival was 62.1%. Analysis of factors influencing sequenlial resection rate revealed HCCs that were single nodule, well encapsulated, situated at right lobe or hepatic hilum, associated with micromodular cirrhosis, and treated with triple or double combination modalities had higher sequential resection rate as compared to their counterparts. Analysis of factors influencing sursival after sequential resection revealed that HCCs with a solitary lumor confined in one lobe, without tumor embolus, and without residual cancer in specimen of sequential resection, had longer survival. It is suggesled that localized unreseelable, solitary, well encapsulated, reght lobe or hilar HCC, associated with micronodular cirrhosis, will be good candidates for cytoreduction and sequential resection; and HCCs with unilateral involvement, without tumor embolus, and with complete necrosis of tumor after multimodality trcatment favored better prognosis.

上传时间

2005年03月11日

合作学者

  • 汤钊猷 邀请

    复旦大学,上海

    尚未开通主页